摘要
系统评价和Meta分析优先报告的条目(Preferred Reporting Items for Systematic Review and Meta-analysis,PRISMA)系列报告规范的陆续发表在一定程度上规范了系统评价/Meta分析报告,本文主要介绍PRISMA-CI的报告条目,并对其进行解读,期望为国内研究人员报告复杂干预性系统评价和Meta分析提供借鉴和参考。
The preferred reporting items for systematic review and Meta-analysis guidelines were published to improve the reporting of systematic reviews and Meta-analysis.The study mainly introduced and interpreted the items of PRISMA-CI,in order to help domestic researchers to perform and report the systematic review and Meta-analysis of complex interventions by PRISMA-CI.
作者
田金徽
马文娟
苟铃珠
陈吉
孙月
王盼杰
张俊华
TIAN Jin-hui;MA Wen-juan;GOU Ling-zhu;CHEN Ji;SUN Yue;WANG Pan-jie;ZHANG Jun-hua(Evidence-based Medicine Center,School of Basic Medical Sciences,Lanzhou University,Gansu Lanzhou 730000,China;Key Laboratory of Clinical Translational Research and Evidence-based Medicine of Gansu Province,Gansu Lanzhou 730000,China;The Second Clinical Medical College of Lanzhou University,Gansu Lanzhou 730000,China;School of Nursing of Lanzhou University,Gansu Lanzhou 730000,China;The First Clinical Medical College of Lanzhou University,Gansu Lanzhou 730000,China;Centre for Evidence-based Medicine Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China)
出处
《中国药物评价》
2018年第1期62-65,共4页
Chinese Journal of Drug Evaluation
